サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751548

バスキュラーアクセス手技の市場規模、シェア、動向分析レポート：手技別、用途別、地域別、セグメント予測、2025年～2030年

Vascular Access Procedures Market Size, Share & Trends Analysis Report, By Procedure (Arteriovenous Fistulas, Arteriovenous Grafts, Central Venous Catheters), By Application, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 140 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.72円
バスキュラーアクセス手技の市場規模、シェア、動向分析レポート：手技別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月06日
発行: Grand View Research
ページ情報: 英文 140 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バスキュラーアクセス手技市場動向：

世界のバスキュラーアクセス手技市場規模は2024年に907億米ドルと推定され、2025年から2030年にかけてCAGR 5.3％で成長すると予測されています。

バスキュラーアクセス手技は、投薬、輸液、透析などの治療のために血流に入るために使用されます。慢性疾患の増加も市場成長を後押しする主な要因の一つです。

2025年2月に発表されたDepartment of Biotechnologyの記事によると、慢性疾患は毎年世界の死亡者の約73％を占めており、長期的で非伝染性疾患への世界の健康状況の大きな変化を反映しています。このような負担の増大により、継続的な治療をサポートする一貫した信頼性の高い医療介入の需要が高まっています。バスキュラーアクセス手技は、化学療法、血液透析、静脈内投薬の安全かつ反復的な投与を可能にし、これらの病態を管理する上で不可欠となっています。ヘルスケアシステムは、長期にわたる慢性疾患の管理にますます重点を置くようになっており、効率的なバスキュラーアクセスソリューションの重要性は増大の一途をたどっており、市場成長の原動力となっています。

がん患者の増加が市場成長の原動力WHOが2024年2月に発表した論文によると、がんは依然として世界の主要な健康負担であり、推定で5人に1人が一生の間にこの病気を発症する可能性があります。死亡率も著しく、男性の約9人に1人、女性の約12人に1人ががんが原因で死亡すると予想されています。予測によれば、新規の罹患者は急増し、2050年には約3,500万人に達し、2022年の推定2,000万人から77％近く増加します。この急激な増加は、効率的な治療の提供、特に化学療法やその他の静脈内治療の実施に不可欠なバスキュラーアクセス手技の緊急の必要性を強調しています。がんの罹患率は、特に高齢化した人々の間で増加の一途をたどっており、低・中所得国では、信頼できるバスキュラーアクセスの需要は、タイムリーで継続的な治療を保証するために極めて重要であり、それによって市場の力強い成長が促進されます。

小児患者に対するバスキュラーアクセス器具の使用の増加が市場成長の原動力となっています。2024年10月に発表されたNCBIの論文によると、2つの大学付属小児集中治療室（PICU）で4年半にわたる長期研究が行われ、220人の小児患者が調査されました。その結果、バスキュラーアクセスデバイスへの依存度が高いことが明らかになり、合計683個のデバイスが使用されました。患者の半数は治療中に3つ以上の器具を必要とし、半数以上（54％）がバスキュラーアクセスに関連した合併症を少なくとも1つは経験していました。この高い使用率とそれに伴う合併症の頻度は、重篤な小児患者の管理におけるバスキュラーアクセス手技の重要な役割を反映しています。このデータは、より高度で安全かつ効率的なバスキュラーアクセスソリューションに対する需要の高まりを浮き彫りにしており、市場の成長をさらに促進しています。

バスキュラーアクセス手技の技術的進歩が市場成長の原動力となっています。2024年10月に発表されたコーネル大学の論文によると、Micro Smart Tissue Autonomous Robot（micro-STAR）は、特に小口径血管の血管吻合を自律的に行う技術的に先進的な手術ロボットです。この装置には光干渉断層計（OCT）とマイクロカメラが搭載されており、安全にナビゲーションし、縫合を完了することができます。生体外試験では、micro-STARは熟練した外科医と同等の結果を示し、人の介在なしに90％の縫合を完了しました。この進歩は、冠動脈バイパス移植術（CABG）や末期腎臓病患者の透析アクセス手術など、細い血管の再接続が必要な手術で特に価値があります。

さらに2025年4月には、6自由度（DoF）のロボットアームと3DoFのエンドエフェクターを組み合わせ、超音波ガイドを利用して小口径の静脈や動脈に正確に針を刺すという、もうひとつの有望な開発も進んでいます。ラットを用いたin vivo研究では、このロボット・システムは95％の初回成功率を達成し、特に、より脆弱で困難な静脈解剖学的構造を持つことが多い小児および老人患者において、困難な血管アクセス・ポイントをナビゲートする能力を示しました。このシステムは、血管奇形、深部静脈血栓症、化学療法関連の静脈アクセスなど、正確で低侵襲なアクセスが重要な病態の治療に有望です。したがって、こうした進歩が市場成長の原動力となっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界のバスキュラーアクセス手技市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • バスキュラーアクセス手技市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 バスキュラーアクセス手技市場：手技別推定・動向分析

  • バスキュラーアクセス手技市場：手技別ダッシュボード
  • バスキュラーアクセス手技市場：手技別変動分析
  • バスキュラーアクセス手技市場規模と予測および動向分析（手技別、2018～2030年）
  • 動静脈瘻
  • 動静脈グラフト
  • 中心静脈カテーテル
  • その他

第5章 バスキュラーアクセス手技市場：用途別の推定・動向分析

  • バスキュラーアクセス手技市場：用途別ダッシュボード
  • バスキュラーアクセス手技市場：用途別変動分析
  • バスキュラーアクセス手技市場規模と予測および動向分析（用途別、2018～2030年）
  • 化学療法
  • 血液透析
  • 輸血
  • 静脈内抗生物質治療
  • その他

第6章 バスキュラーアクセス手技市場：地域別の推定・動向分析

  • 世界のバスキュラーアクセス手技市場：地域別ダッシュボード
  • 市場規模と予測動向分析、2018年から2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要メーカーによる最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店およびチャネルパートナーのリスト
    • Key customers
    • Key company analysis, 2024
    • Teleflex Medical
    • BD
    • B. Braun
    • Smith's Medical（ICU Medical, Inc）
    • Cook Medical
    • AngioDynamics
    • Medtronic
    • Medical Components, Inc.
    • Cook Medical
    • Terumo Medical Corporation
    • Access Vascular, Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 4 Global vascular access procedures market, by application, 2018 - 2030
  • Table 5 Global vascular access procedures market, by region, 2018 - 2030 (USD Billion)
  • Table 6 North America vascular access procedures market, by country, 2018 - 2030 (USD Billion)
  • Table 7 North America vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 8 North America vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 9 U.S vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 10 U.S vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 11 Canada vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 12 Canada vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 13 Mexico vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 14 Mexico vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 15 Europe vascular access procedures market, by country, 2018 - 2030 (USD Billion)
  • Table 16 Europe vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 17 Europe vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 18 UK vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 19 Germany vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 20 Germany vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 21 France vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 22 France vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 23 Italy vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 24 Italy vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 25 Spain vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 26 Spain vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 27 Denmark vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 28 Denmark vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 29 Sweden vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 30 Sweden vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 31 Norway vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 32 Norway vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 33 Asia Pacific vascular access procedures market, by country, 2018 - 2030 (USD Billion)
  • Table 34 Asia Pacific vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 35 Asia Pacific vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 36 Japan vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 37 Japan vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 38 China vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 39 China vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 40 India vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 41 India vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 42 Australia vascular access procedures market, by country, 2018 - 2030 (USD Billion)
  • Table 43 Australia vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 44 Australia vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 45 Thailand vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 46 Thailand vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 47 South Korea vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 48 South Korea vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 49 Latin America vascular access procedures market, by country, 2018 - 2030 (USD Billion)
  • Table 50 Latin America vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 51 Latin America vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 52 Brazil vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 53 Brazil vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 54 Argentina vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 55 Argentina vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 56 MEA vascular access procedures market, by country, 2018 - 2030 (USD Billion)
  • Table 57 MEA vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 58 MEA vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 59 South Africa vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 60 South Africa vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 61 Saudi Arabia vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 62 Saudi Arabia vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 63 UAE vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 64 UAE vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 65 Kuwait vascular access procedures market, by procedure type, 2018 - 2030 (USD Billion)
  • Table 66 Kuwait vascular access procedures market, by application, 2018 - 2030 (USD Billion)
  • Table 67 Participant's overview
  • Table 68 Financial performance
  • Table 69 Key companies undergoing expansions
  • Table 70 Key companies undergoing acquisitions
  • Table 71 Key companies undergoing collaborations
  • Table 72 Key companies launching new products
  • Table 73 Key companies undergoing partnerships
  • Table 74 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Vascular access procedures market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Vascular access procedures market revenues, 2024 (USD Billions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Vascular access procedures market: Procedure type outlook:
  • Fig. 14 Vascular access procedures market: Procedure type movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global arteriovenous fistulas market, 2018 - 2030 (USD Billion)
  • Fig. 17 Global arteriovenous grafts market, 2018 - 2030 (USD Billion)
  • Fig. 18 Global central venous catheters market, 2018 - 2030 (USD Billion)
  • Fig. 19 Global others market, 2018 - 2030 (USD Billion)
  • Fig. 20 Vascular access procedures market application outlook:
  • Fig. 21 Vascular access procedures market: application movement analysis
  • Fig. 22 Global chemotherapy market, 2018 - 2030 (USD Billion)
  • Fig. 23 Global hemodialysis market, 2018 - 2030 (USD Billion)
  • Fig. 24 Global intravenous antibiotics treatment market, 2018 - 2030 (USD Billion)
  • Fig. 25 Global intravenous blood transfusions market, 2018 - 2030 (USD Billion)
  • Fig. 26 Global others market, 2018 - 2030 (USD Billion)
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 North America vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 29 U.S vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 30 Canada vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 31 Mexico vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 32 Europe vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 33 Germany vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 34 UK vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 35 France vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 36 Italy vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 37 Spain vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 38 Asia Pacific vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 39 Japan vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 40 China vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 41 India vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 42 Australia vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 43 Latin America vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 44 Brazil vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 45 MEA vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 46 South Africa vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 47 Saudi Arabia vascular access procedures market, 2018 - 2030 (USD Billion)
  • Fig. 48 Market Participant Categorization
  • Fig. 49 Strategy mapping
目次
Product Code: GVR-4-68040-566-7

Vascular Access Procedures Market Trends:

The global vascular access procedures market size was estimated at USD 90.7 billion in 2024 and is projected to grow at a CAGR of 5.3% from 2025 to 2030. Vascular access procedures are used to enter the bloodstream for treatments like medication, fluids, or dialysis. The increasing incidence of chronic diseases is one of the major factors boosting market growth.

According to the Department of Biotechnology article published in February 2025, chronic diseases account for around 73% of deaths globally every year, reflecting a significant shift in the global health landscape toward long-term, non-communicable conditions. This growing burden has intensified the demand for consistent and reliable medical interventions that support ongoing treatment. Vascular access procedures have become critical in managing these conditions, enabling the safe and repeated administration of chemotherapy, hemodialysis, and intravenous medications. The healthcare systems increasingly focus on managing chronic illnesses over extended periods, and the importance of efficient vascular access solutions continues to grow, driving market growth.

Increased cancer cases drive the market growth. According to the WHO article published in February 2024, Cancer remains a leading global health burden, with an estimated 1 in 5 people likely to develop the disease during their lifetime. Mortality rates are also significant, with about 1 in 9 men and 1 in 12 women expected to die from cancer-related causes. Projections indicate a steep rise in new cases, reaching approximately 35 million by 2050, up nearly 77% from the estimated 20 million in 2022. This sharp increase underscores the urgent need for efficient treatment delivery, particularly vascular access procedures, critical for administering chemotherapy and other intravenous therapies. The cancer incidence continues to grow, especially among aging populations, and in low- to middle-income countries, the demand for dependable vascular access will be crucial to ensuring timely and continuous care, thereby driving strong market growth.

Increasing use of vascular access devices for pediatric patients drives the market's growth. According to an NCBI article published in October 2024, a long-term study spanning 4.5 years in two university-affiliated Pediatric Intensive Care Units (PICUs) examined 220 pediatric patients. It revealed significant dependence on vascular access devices, with a total of 683 devices utilized. Half of the patients required three or more devices during their treatment, and over half (54%) experienced at least one complication related to vascular access. This high usage rate and associated complication frequency reflect the critical role of vascular access procedures in managing seriously ill pediatric populations. The data highlights a growing demand for advanced, safer, and more efficient vascular access solutions, further driving the market growth.

Technological advancements in vascular access procedures drive the market growth. According to the Cornell University article published in October 2024, the Micro Smart Tissue Autonomous Robot (micro-STAR), a technologically advanced surgical robot that autonomously performs vascular anastomosis, particularly on small-diameter blood vessels. This device is equipped with Optical Coherence Tomography (OCT) and a microcamera, allowing it to navigate and complete sutures safely. In ex vivo studies, micro-STAR demonstrated outcomes on par with those of experienced surgeons, completing 90% of sutures without human intervention. This advancement is particularly valuable in surgeries requiring the reconnection of small vessels, such as in coronary artery bypass grafting (CABG) and dialysis access surgery for patients with end-stage renal disease.

Moreover, in April 2025, another promising development is integrating a 6-degrees-of-freedom (DoF) robotic arm combined with a 3-DoF end-effector, which utilizes ultrasound guidance to perform precise needle insertion into small-diameter veins and arteries. In in vivo studies on rats, this robotic system achieved a 95% first-attempt success rate, showcasing its ability to navigate difficult vascular access points, particularly in pediatric and geriatric patients who often have more fragile and challenging venous anatomy. This system holds potential for treating conditions like vascular malformations, deep vein thrombosis, and chemotherapy-related venous access, where accurate and minimally invasive access is critical. Thus, these advancements drive the market growth.

Global Vascular Access Procedures Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and analyzes the industry trends in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the global vascular access procedures market report based on procedure type, application, and region:

  • Procedure Outlook (Revenue, USD Billion, 2018 - 2030)
  • Arteriovenous Fistulas
  • Arteriovenous Grafts
  • Central Venous Catheters
  • Others
  • Application Outlook (Revenue, USD Billion, 2018 - 2030)
  • Chemotherapy
  • Hemodialysis
  • Blood Transfusions
  • Intravenous Antibiotics Treatment
  • Others
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Procedure
    • 1.2.2. Application
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Procedure Segment
    • 2.2.2. Application Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Vascular Access Procedures Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rise in chronic incidence
      • 3.2.1.2. Increasing use of vascular access devices for pediatric patients
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost associated with the devices and procedures
      • 3.2.2.2. Complications and risk of infection
  • 3.3. Vascular Access Procedures Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Vascular Access Procedures Market: Procedure Estimates & Trend Analysis

  • 4.1. Vascular Access Procedures Market: Procedure Dashboard
  • 4.2. Vascular Access Procedures Market: Procedure Movement Analysis
  • 4.3. Vascular Access Procedures Market Size & Forecasts and Trend Analysis, by Procedure, 2018 to 2030 (USD Billion)
  • 4.4. Arteriovenous Fistulas
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 4.5. Arteriovenous Grafts
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 4.6. Central Venous Catheters
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 4.7. Others
    • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 5. Vascular Access Procedures Market: Application Estimates & Trend Analysis

  • 5.1. Vascular Access Procedures Market: Application Dashboard
  • 5.2. Vascular Access Procedures Market: Application Movement Analysis
  • 5.3. Vascular Access Procedures Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Chemotherapy
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 5.5. Hemodialysis
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 5.6. Blood Transfusions
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 5.7. Intravenous Antibiotics Treatment
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Billion)
  • 5.8. Others
    • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 6. Vascular Access Procedures Market: Regional Estimates & Trend Analysis by Country, Procedure, & Application

  • 6.1. Global Vascular Access Procedures Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Billion)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company analysis, 2024
    • 7.3.4. Teleflex Medical
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. BD
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. B. Braun
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Smith's Medical (ICU Medical, Inc)
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Cook Medical
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. AngioDynamics
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Medtronic
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Medical Components, Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Cook Medical
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Terumo Medical Corporation
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Access Vascular, Inc.
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives